Drug and alcohol abuse and dependency, along with all of the medical and behavioral complications of drug abuse, ranging from hepatitis B and delta, cirrhosis and AIDS to psychiatric disorders and sociopathic behaviors, are the major medical problems confronting our nation and the world today. Effective treatments, based on fundamental knowledge about the drugs of abuse, pharmacologic agents used in the treatment of drug abuse, and the biological bases of addictive disease, as well as information about and approaches to the management of medical and behavioral problems which may complicate treatment, are needed urgently. Heroin abuse continues to afflict over 2 million persons at this time, with over one-half million """"""""hard-core"""""""" heroin addicts in the United States, constituting the greatest numbers of patients in the second highest risk group for AIDS. Cocaine abuse continues to escalate, with around 6 million persons now reported to be regular users of cocaine and with increasing numbers using the more potent free-base form, """"""""crack"""""""". The central theme of the proposed Center will be to identify and study the biological correlates of treatment of addictions, and as a major part of this effort, to study in depth several factors which may negatively, and also positively, affect treatment outcome. Problems such as medical and behavioral including pharmacological, metabolic and behavioral aspects of treatments, will be studied. In addition, some studies will attempt to elucidate further the biological bases of addictive diseases, with the goal of developing in the future novel, improved or more specific pharmacological as well as behavioral approaches for the treatment of various addictions. To the same end, with the goal of developing new or modifying existing treatments to improve both short- and long-term treatment outcome, studies are proposed to delineate the effects of existing treatments on those aspects of physiology which may by intrinsically involved with the addictive disease process, or which may, by inadvertent alterations of physiology, contribute to treatment failure. In the proposed Center, studies of basic science, basic clinical research, and applied clinical research types will all be focused on the central theme of studying the biological correlates of the treatment of addiction. These various scientific approaches will be integrated through the Core Resources and other interactions which only a Center can appropriately provide.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA005130-04
Application #
3105382
Study Section
Special Emphasis Panel (SRCD (38))
Project Start
1987-09-30
Project End
1992-08-31
Budget Start
1990-09-30
Budget End
1991-08-31
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Gasser, Paul J; Hurley, Matthew M; Chan, June et al. (2017) Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct 222:1913-1928
Butelman, Eduardo Roque; Bacciardi, Silvia; Maremmani, Angelo Giovanni Icro et al. (2017) Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity? Am J Addict 26:632-639
Schwantes-An, Tae-Hwi; Zhang, Juan; Chen, Li-Shiun et al. (2016) Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. Behav Genet 46:151-69
Randesi, Matthew; van den Brink, Wim; Levran, Orna et al. (2016) Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. Drug Alcohol Depend 168:164-169
Garzón, Miguel; Pickel, Virginia M (2016) Electron microscopic localization of M2-muscarinic receptors in cholinergic and noncholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei of the rat mesopontine tegmentum. J Comp Neurol 524:3084-103
Zhou, Yan; Leri, Francesco; Cummins, Erin et al. (2015) Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats. Physiol Behav 139:127-35
Deutsch-Feldman, Molly; Picetti, Roberto; Seip-Cammack, Katharine et al. (2015) Effects of handling and vehicle injections on adrenocorticotropic and corticosterone concentrations in Sprague-Dawley compared with Lewis rats. J Am Assoc Lab Anim Sci 54:35-9
Zaaijer, Eline R; Bruijel, Jessica; Blanken, Peter et al. (2014) Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. Drug Alcohol Depend 145:101-5
Levran, Orna; Randesi, Matthew; Li, Yi et al. (2014) Drug addiction and stress-response genetic variability: association study in African Americans. Ann Hum Genet 78:290-8
Levran, O; Peles, E; Randesi, M et al. (2014) Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype. Psychoneuroendocrinology 45:67-76

Showing the most recent 10 out of 151 publications